United States. Securities and Exchange Commission
A U.S. Securities and Exchange Commission filing by Moderna, Inc. has been posted, detailing the company's information as of August 5, 2022. The filing, processed by the SEC, discloses financial transactions and ownership details of the company. Moderna, Inc. is a publicly-traded biotechnology company focused on developing
United States. Securities and Exchange Commission
Biogen Inc., a leading biopharmaceutical company, submitted a Form 8-K filing with the U.S. Securities and Exchange Commission (SEC) on June 21, 2022. The filing, available on the SEC's website, reveals 12 documents submitted by the company. This filing is a "current report" that highlights
United States. Securities and Exchange Commission
A recent SEC filing by La Jolla Pharmaceutical Co has highlighted the company's biopharmaceutical activities. The document, filed on June 17, 2022, reveals the company's focus on biological products and diagnostic substances. According to the filing, the company is committed to transparency and compliance with SEC
United States. Securities and Exchange Commission
According to a U.S. Securities and Exchange Commission (SEC) filing, Amgen Inc. submitted a Form 4 notification on November 9, 2021, disclosing changes in ownership of the company's equity securities. The Form 4 filing is a required statement for directors, officers, or owners with more than 10%
United States. Securities and Exchange Commission
On November 22, 2021, Heska Corporation held a special meeting of stockholders, where shareholders voted to approve a Certificate of Amendment to the company's Restated Certificate of Incorporation. The amendment increased the number of authorized shares of each class of Heska Corporation's Common Stock from 13,
Vaccines
The International Olympic Committee (IOC) has secured a donation of COVID-19 vaccines from Pfizer Inc. and BioNTech SE for participants in the Olympic and Paralympic Winter Games Beijing 2022. This move builds on a Memorandum of Understanding reached in May for the companies to donate vaccines to the Olympic and
Vaccines
As the COVID-19 pandemic surges nationwide, a growing number of governors from both parties are opting out of federal guidance on coronavirus booster shots, paving the way for anyone over 18 to receive the vaccine. This dramatic shift in policy comes as federal officials continue to limit booster eligibility to
United States. Securities and Exchange Commission
According to a U.S. Securities and Exchange Commission (SEC) filing, Amgen Inc. has submitted a notification of ownership regarding its equity securities. The filing was made on August 10, 2021, and provides information about the company's directors, officers, and owners of more than 10% of its equity
United States. Securities and Exchange Commission
Acorda Therapeutics, a biotechnology company based in New York, has reported the resignation of two members of its board of directors: Barry Greene and Catherine D. Strader, Ph.D. The news was announced in the company's Form 8-K filing with the Securities and Exchange Commission on August 23,
COVID-19 vaccines
AstraZeneca has secured crucial approval for a revolutionary new medicine that will greatly improve the lives of Scots cancer patients with the most common form of leukaemia. The Scottish Medicines Consortium has greenlit acalabrutinib, an oral pill that can be taken at home, which targets the disease while minimizing debilitating
COVID-19 vaccines
The Jupiter Global Sustainable Equities Fund, managed by Abbie Llewellyn-Waters, has excelled in the healthcare sector during the past year. The fund's focus on preventative healthcare and economically sustainable companies has led it to invest in top-performing brands such as CSL and Danaher. These companies have played a
COVID-19 vaccines
The Serum Institute of India (SII), the maker of Covishield, has joined the ranks of foreign vaccine companies like Pfizer and Moderna in seeking indemnity for vaccine failures or side effects. This follows the government's hint at granting indemnity to Pfizer and Moderna, a condition put forth by
